Press Releases

Launch of a mutant RNA T7 polymerase with highly reduced double-stranded RNA formation

Takara Bio announces the launch of PrimeCap™ T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development.

​​Elsevier Introduces SciBite Chat, a transformative AI-Powered Semantic Search Tool for Life Sciences ​

Elsevier, a global leader in information and analytics, today announced the launch of SciBite Chat, a new AI-powered interface built atop SciBite Search, SciBite’s award-winning platform. SciBite Chat uniquely combines the strength of semantic search for accurate and traceable information retrieval and Large Language Models (LLMs) for interpreting human language and answer generation.

PathAI Announces PLUTO: a State-of-the-Art Foundation Model to Enhance AI-powered Pathology Tools

PLUTO’s embeddings will enable prediction of underlying molecular alterations driving cancer and disease phenotypes–including those previously hidden to AI–as well as the discovery of new biomarkers and therapeutic targets.

Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform

Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.

Watson-Marlow introduces DriveSure® OEM pump solution at ACHEMA 2024

Falmouth UK, 14th May 2024 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) will showcase its recently launched DriveSure® panel mount pumps along with other products for life sciences companies at ACHEMA 2024 in Germany (June 10-14).

Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis Panels

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS). The company also reduced its standard turnaround time on WES and WGS to three weeks and continues to provide rapid testing with written reports in as few as five days.

Amerigo Scientific Adds Magnetic Silica Beads to Enlarge Its Nucleic Acid Extraction and Purification Toolbox

Verisense Health Elects Josh Tolkoff to its Board of Directors

Josh brings extensive medical device, investment, and growth management experience to his new role.

CD Formulation Unveils Hydrogel Microneedle Patch Technology to Increase Drug Loading Capacity

BBI and BioAgilytix partner to streamline and simplify bioanalytical testing

BBI Solutions has signed a partnership agreement with BioAgilytix

Alfa Chemistry Rolls Out Various Nucleic Acid Delivery Options for Nucleotide Vaccine Research

REVIAN Inc.'s plans for a second study of the Revian Red Hair Growth System to evaluate its efficacy as a treatment option for Central Centrifugal Cicatricial Alopecia ("CCCA")

Clinical studies have shown that minoxidil can effectively promote hair regrowth in individuals with alopecia areata, particularly in mild to moderate hair loss cases. Results may vary from person to person, and not everyone may respond to minoxidil treatment. To see the best results, it's also essential to use minoxidil consistently and as directed. This means applying it regularly to the affected areas of the scalp and continuing treatment even after hair regrowth occurs to maintain results.

Firstsource Acquires Quintessence

Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI

Quest Diagnostics, a leader in diagnostic information services, and PathAI, a global provider of AI-powered pathology technology, have joined forces to accelerate digital and AI pathology innovations. This collaboration aims to enhance the quality, speed, and efficiency of diagnosing cancer and other diseases, marking a monumental advancement in medical diagnostics.

ELRIG UK Announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024

ELRIG UK announced the keynote speakers for its flagship conference, Drug Discovery 2024: Ijeoma Uchegbu FMedSci, Professor of Pharmaceutical Nanoscience at University College London (UCL) and Chief Scientific Officer (CSO) at Nanomerics, and Marcus Schindler PhD, CSO and Executive Vice President of Research and Early Development at Novo Nordisk.

CPHI North America experts ‘mid-sized domestic CDMOs need to invest in operational efficiencies to drive “real” reshoring’

Supply chain resilience and new partner sourcing to benefit from a boom in outsourcing in 2025

Watson-Marlow advances its OEM panel mount solution DriveSure with latest technology

Watson-Marlow Fluid Technology Solutions (WMFTS) has advanced DriveSure® with the latest technology to offer a complete peristaltic panel mount pump solution for original equipment manufacturers (OEMs).

Hoag Health System Selects PathAI and the AISight Image Management System to Support the Transition To Digital and AI-enabled Pathology

PathAI, a leading precision pathology company, today announced that Hoag Health System, the leading health system in the southern California region, will adopt the AISight Image Management System (IMS) as their primary platform, powering their transition to digital pathology. The transition from analog, glass-slide-based pathology to digital pathology continues to accelerate across anatomic pathology, globally. This transition is in part driven by the availability of AI pathology tools that harness machine learning (ML) algorithms to augment and assist the pathologist interpretation.

Using AI to Improve Diagnosis of Rare Genetic Disorders

Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to make the process more efficient using artificial intelligence. The team developed a machine learning system called AI-MARRVEL (AIM) to help prioritize potentially causative variants for Mendelian disorders. The study is published today in NEJM AI. Researchers from the Baylor Genetics clinical diagnostic laboratory noted that AIM's module can contribute to predictions independent of clinical knowledge of the gene of interest, helping to advance the discovery of novel disease mechanisms.

SpecialtyVETPATH Taps Proscia For A Full Transformation Of Its Pathology Operations

Advancing diagnosis and research with an enterprise software platform